The joint program of Fox Chase Cancer Center and Temple University Hospital earned accreditation by the Foundation for the Accreditation of Cellular Therapy at the University of Nebraska Medical Center for adult allogeneic and autologous hematopoietic progenitor cell transplantation, peripheral blood cellular therapy product collection, and cellular therapy product processing with minimal manipulation.
Richard Pazdur, FDA’s top oncologist who last week received a battlefield promotion to the role of director of the FDA Center for Drug Evaluation and Research, is described as a stabilizing figure respected by major patient groups, oncology professional societies, and the industry.
